Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR.

MLA

Dey, Nandini, et al. “Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving PCR.” Cancers, vol. 13, no. 3, Feb. 2021, p. 458. EBSCOhost, https://doi.org/10.3390/cancers13030458.

APA

Dey, N., Aske, J., De, P., & Picard, D. (2021). Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR. Cancers, 13(3), 458. https://doi.org/10.3390/cancers13030458

Chicago

Dey, Nandini, Jennifer Aske, Pradip De, and Didier Picard. 2021. “Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving PCR.” Cancers 13 (3): 458. doi:10.3390/cancers13030458.